Salazar Gómez, L. and Grisales Negrete, J.P. 2022. Molecular and clinical evidence of the cardiovascular benefit of SGLT2 inhibitors: State of the art. Medicina UPB. 41, 2 (Aug. 2022), 145–156. DOI:https://doi.org/10.18566/medupb.v41n2.a07.